Non-coding RNAs play an important regulatory role in cancer glucose metabolism. Non-coding RNA research areas include small RNAs, long non-coding RNAs, and circular RNAs. Elucidating the expression changes, roles, molecular mechanisms and clinical significance of non-coding RNAs in the process of cancer glucose metabolism provides a new perspective for a complete understanding of cancer metabolic reprogramming and the mechanism of cancer occurrence and development. CD BioGlyco can provide the MOPCGM platform-based analysis of the differential expression of non-coding RNAs in the process of cancer glucose metabolism reprogramming, the analysis of the molecular mechanism of non-coding RNAs affecting cancer progression by regulating glucose metabolism, the analysis of the clinical significance of non-coding RNAs on cancer diagnosis and prognosis, etc.
Using biochip technology, we can provide differential expression analysis of non-coding RNAs in various samples such as cancer cells treated with different glucose metabolism regulators, cancer cells with different metabolic phenotypes, and cancer types with different metabolic characteristics.Fig. 1 The regulatory roles of lncRNAs in glucose metabolism
CD BioGlyco provides differential expression analysis services of non-coding RNAs related to cancer glucose metabolism, molecular mechanism analysis services of non-coding RNAs regulating glucose metabolism pathways, and analysis services of non-coding RNAs as markers of metabolic reprogramming. Our experienced teams of scientists, researchers, and technicians provide fast turnaround, high-quality services at competitive prices for worldwide customers. Our customers have direct access to our staff and prompt feedback on their inquiries. If you are interested in our services, please contact us for more details.